Fluofarma has developed proprietary cellular probes based on fluorescent fusion proteins. Our cellular probes can report on specific molecular events involved in a range of physiopathological processes such as cancer, neurodegenerative disease and aging.
Fluofarma’s cellular probes enable compounds screening which focuses on a specific biological event and can help understand the compound’s mechanism of action.
If you need to have further details on our cellular probes, do not hesitate to contact us.
FOCUS: Anticancer drugs profiling
Fluofarma has developed DCffer® method, a powerful approach to
compare and profile your anti-cancer drugs. Read
more [+]